Skip to main content
. 2021 Nov 25;9(4):191. doi: 10.3390/pharmacy9040191

Table 1.

Demographics.

Characteristic All Patients
(n = 193)
Intervention
(n = 110)
Control
(n = 83)
p a
Mean age, years 66.5 65.1 68.3 0.17
Male 111 (57.5) 59 (53.6) 52 (62.7) 0.21
Caucasian 173 (89.6) 100 (90.9) 73 (88.0) 0.66
African American 17 (8.8) 9 (8.2) 8 (9.6)
Native Hawaiian/Pacific Islander 3 (1.6) 1 (0.9) 2 (2.4)
MSSA 112 (58.0) 65 (59.1) 47 (56.6) 0.73
MRSA 81 (42.0) 45 (40.9) 36 (43.4)
Mean Charlson Comorbidity Index 4.04 4.02 4.06 0.76

Data are presented as No. of patients (%) unless specified otherwise. Abbreviations: MSSA, methicillin-sensitive Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus. a p for intervention group vs. control group.